- Home
- / Harmony Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Harmony Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$41.5
2024-10-29
Market Capitalization
$2.4 B
2024-10-29
Revenue
$714.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jul 11, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|
| Revenue | 159.7M | 305.4M | 437.9M | 582.0M | 714.7M |
| Cost of goods sold | 27.7M | 55.5M | 83.5M | 121.2M | 156.8M |
| Gross profit | 132.0M | 249.9M | 354.4M | 460.8M | 557.9M |
| Gross profit margin, % | 82.6% | 81.8% | 80.9% | 79.2% | 78.1% |
| General and administrative expense | 39.7M | 63.9M | 84.0M | 95.3M | 110.4M |
| Operating expense total | 115.0M | 162.4M | 234.2M | 268.8M | 367.1M |
| EBIT | 17.0M | 87.5M | 120.2M | 192.0M | 190.8M |
| EBIT margin, % | 10.6% | 28.7% | 27.4% | 33.0% | 26.7% |
| Investment income | 14.7M | 18.5M | |||
| Interest expense | 28.2M | 24.2M | 18.8M | 23.8M | 17.5M |
| Pre tax profit | (36.9M) | 37.4M | 104.7M | 173.4M | 191.8M |
| Income tax expense | 4.2M | 2.8M | (76.8M) | 44.5M | 46.3M |
| Net Income | (36.9M) | 34.6M | 181.5M | 128.9M | 145.5M |
| EPS | (2.5) | 0.6 | 3.0 | 2.1 | 2.5 |